Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Commensal Strains of Neisseria Use DNA to Poison Their Pathogenic Rivals.

Fleming BA, Mulvey MA.

Cell Host Microbe. 2019 Aug 14;26(2):156-158. doi: 10.1016/j.chom.2019.07.014.

PMID:
31415746
2.

Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection.

Forde BM, Roberts LW, Phan MD, Peters KM, Fleming BA, Russell CW, Lenherr SM, Myers JB, Barker AP, Fisher MA, Chong TM, Yin WF, Chan KG, Schembri MA, Mulvey MA, Beatson SA.

Nat Commun. 2019 Aug 13;10(1):3643. doi: 10.1038/s41467-019-11571-5.

3.

Jekyll and Hyde: Bugs with Double Personalities that Muddle the Distinction between Commensal and Pathogen.

Brannon JR, Mulvey MA.

J Mol Biol. 2019 Jul 26;431(16):2911-2913. doi: 10.1016/j.jmb.2019.06.014. Epub 2019 Jun 18. No abstract available.

PMID:
31226308
4.

Electronic health record cue identifies epilepsy patients at risk for obstructive sleep apnea.

Mulvey MA, Veerapandiyan A, Marks DA, Ming X.

Neurol Clin Pract. 2018 Dec;8(6):468-471. doi: 10.1212/CPJ.0000000000000502.

5.

Context-Dependent Requirements for FimH and Other Canonical Virulence Factors in Gut Colonization by Extraintestinal Pathogenic Escherichia coli.

Russell CW, Fleming BA, Jost CA, Tran A, Stenquist AT, Wambaugh MA, Bronner MP, Mulvey MA.

Infect Immun. 2018 Feb 20;86(3). pii: e00746-17. doi: 10.1128/IAI.00746-17. Print 2018 Mar.

6.

High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance.

Wambaugh MA, Shakya VPS, Lewis AJ, Mulvey MA, Brown JCS.

PLoS Biol. 2017 Jun 20;15(6):e2001644. doi: 10.1371/journal.pbio.2001644. eCollection 2017 Jun.

7.

The Rhomboid Protease GlpG Promotes the Persistence of Extraintestinal Pathogenic Escherichia coli within the Gut.

Russell CW, Richards AC, Chang AS, Mulvey MA.

Infect Immun. 2017 May 23;85(6). pii: e00866-16. doi: 10.1128/IAI.00866-16. Print 2017 Jun.

8.

Dual colorimetric and fluorogenic probes for visualizing tyrosine phosphatase activity.

Biswas S, McCullough BS, Ma ES, LaJoie D, Russell CW, Garrett Brown D, Round JL, Ullman KS, Mulvey MA, Barrios AM.

Chem Commun (Camb). 2017 Feb 14;53(14):2233-2236. doi: 10.1039/c6cc09204g.

PMID:
28144650
9.

Escherichia coli O78 isolated from septicemic lambs shows high pathogenicity in a zebrafish model.

Kjelstrup CK, Barber AE, Norton JP, Mulvey MA, L'Abée-Lund TM.

Vet Res. 2017 Jan 25;48(1):3. doi: 10.1186/s13567-016-0407-0.

10.

Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.

Erman A, Hergouth VK, Blango MG, Kos MK, Mulvey MA, Veranic P.

J Infect Dis. 2017 Aug 1;216(3):375-381. doi: 10.1093/infdis/jix023.

11.

Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Lewis AJ, Richards AC, Mulvey MA.

Microbiol Spectr. 2016 Dec;4(6). doi: 10.1128/microbiolspec.UTI-0026-2016. Review.

12.

Similarly Lethal Strains of Extraintestinal Pathogenic Escherichia coli Trigger Markedly Diverse Host Responses in a Zebrafish Model of Sepsis.

Barber AE, Fleming BA, Mulvey MA.

mSphere. 2016 Apr 20;1(2). pii: e00062-16. doi: 10.1128/mSphere.00062-16. eCollection 2016 Mar-Apr.

13.

Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Barber AE, Norton JP, Wiles TJ, Mulvey MA.

Microbiol Mol Biol Rev. 2016 Mar 2;80(2):351-67. doi: 10.1128/MMBR.00067-15. Print 2016 Jun. Review.

14.

Histone Deacetylase 6 Regulates Bladder Architecture and Host Susceptibility to Uropathogenic Escherichia coli.

Lewis AJ, Dhakal BK, Liu T, Mulvey MA.

Pathogens. 2016 Feb 14;5(1). pii: E20. doi: 10.3390/pathogens5010020.

15.

The Extraintestinal Pathogenic Escherichia coli Factor RqlI Constrains the Genotoxic Effects of the RecQ-Like Helicase RqlH.

Russell CW, Mulvey MA.

PLoS Pathog. 2015 Dec 4;11(12):e1005317. doi: 10.1371/journal.ppat.1005317. eCollection 2015 Dec.

16.

Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs.

Blango MG, Ott EM, Erman A, Veranic P, Mulvey MA.

PLoS One. 2014 Mar 25;9(3):e93327. doi: 10.1371/journal.pone.0093327. eCollection 2014.

17.

Reply to Kaye and Sobel.

Barber AE, Mulvey MA.

Clin Infect Dis. 2014 Feb;58(3):444-5. doi: 10.1093/cid/cit706. Epub 2013 Oct 24. No abstract available.

18.

Combining quantitative genetic footprinting and trait enrichment analysis to identify fitness determinants of a bacterial pathogen.

Wiles TJ, Norton JP, Russell CW, Dalley BK, Fischer KF, Mulvey MA.

PLoS Genet. 2013;9(8):e1003716. doi: 10.1371/journal.pgen.1003716. Epub 2013 Aug 22.

19.

Urinary tract infections: current and emerging management strategies.

Barber AE, Norton JP, Spivak AM, Mulvey MA.

Clin Infect Dis. 2013 Sep;57(5):719-24. doi: 10.1093/cid/cit284. Epub 2013 May 3. Review.

20.

A phyletically rare gene promotes the niche-specific fitness of an E. coli pathogen during bacteremia.

Wiles TJ, Norton JP, Smith SN, Lewis AJ, Mobley HL, Casjens SR, Mulvey MA.

PLoS Pathog. 2013 Feb;9(2):e1003175. doi: 10.1371/journal.ppat.1003175. Epub 2013 Feb 14.

21.

The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli.

Debnath I, Norton JP, Barber AE, Ott EM, Dhakal BK, Kulesus RR, Mulvey MA.

Infect Immun. 2013 May;81(5):1450-9. doi: 10.1128/IAI.01213-12. Epub 2013 Feb 19.

22.

The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.

Wiles TJ, Mulvey MA.

Future Microbiol. 2013 Jan;8(1):73-84. doi: 10.2217/fmb.12.131. Review.

23.

Adenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli.

Donovan GT, Norton JP, Bower JM, Mulvey MA.

Infect Immun. 2013 Jan;81(1):249-58. doi: 10.1128/IAI.00796-12. Epub 2012 Oct 31.

24.

Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets.

Kraemer BF, Campbell RA, Schwertz H, Franks ZG, Vieira de Abreu A, Grundler K, Kile BT, Dhakal BK, Rondina MT, Kahr WH, Mulvey MA, Blaylock RC, Zimmerman GA, Weyrich AS.

Blood. 2012 Dec 13;120(25):5014-20. doi: 10.1182/blood-2012-04-420661. Epub 2012 Oct 18.

25.

Toxin-antitoxin systems are important for niche-specific colonization and stress resistance of uropathogenic Escherichia coli.

Norton JP, Mulvey MA.

PLoS Pathog. 2012;8(10):e1002954. doi: 10.1371/journal.ppat.1002954. Epub 2012 Oct 4.

26.

Uropathogenic Escherichia coli induces serum amyloid a in mice following urinary tract and systemic inoculation.

Erman A, Lakota K, Mrak-Poljsak K, Blango MG, Krizan-Hergouth V, Mulvey MA, Sodin-Semrl S, Veranic P.

PLoS One. 2012;7(3):e32933. doi: 10.1371/journal.pone.0032933. Epub 2012 Mar 12.

27.
28.

The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia.

Vigil PD, Wiles TJ, Engstrom MD, Prasov L, Mulvey MA, Mobley HL.

Infect Immun. 2012 Feb;80(2):493-505. doi: 10.1128/IAI.05713-11. Epub 2011 Nov 14.

29.

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Blango MG, Mulvey MA.

Antimicrob Agents Chemother. 2010 May;54(5):1855-63. doi: 10.1128/AAC.00014-10. Epub 2010 Mar 15.

30.

Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.

Wiles TJ, Bower JM, Redd MJ, Mulvey MA.

PLoS Pathog. 2009 Dec;5(12):e1000697. doi: 10.1371/journal.ppat.1000697. Epub 2009 Dec 18.

31.

Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli.

Kulkarni R, Dhakal BK, Slechta ES, Kurtz Z, Mulvey MA, Thanassi DG.

PLoS One. 2009;4(3):e4752. doi: 10.1371/journal.pone.0004752. Epub 2009 Mar 9.

32.

Conditioning of uropathogenic Escherichia coli for enhanced colonization of host.

Bower JM, Gordon-Raagas HB, Mulvey MA.

Infect Immun. 2009 May;77(5):2104-12. doi: 10.1128/IAI.01200-08. Epub 2009 Mar 2.

33.

Bacterial landlines: contact-dependent signaling in bacterial populations.

Blango MG, Mulvey MA.

Curr Opin Microbiol. 2009 Apr;12(2):177-81. doi: 10.1016/j.mib.2009.01.011. Epub 2009 Feb 24. Review.

34.

Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway.

Dhakal BK, Mulvey MA.

J Biol Chem. 2009 Jan 2;284(1):446-54. doi: 10.1074/jbc.M805010200. Epub 2008 Nov 6.

35.

Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells.

Eto DS, Gordon HB, Dhakal BK, Jones TA, Mulvey MA.

Cell Microbiol. 2008 Dec;10(12):2553-67. doi: 10.1111/j.1462-5822.2008.01229.x. Epub 2008 Aug 25.

PMID:
18754852
36.

Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli.

Dhakal BK, Kulesus RR, Mulvey MA.

Eur J Clin Invest. 2008 Oct;38 Suppl 2:2-11. doi: 10.1111/j.1365-2362.2008.01986.x. Epub 2008 Jul 8. Review.

PMID:
18616559
37.

Origins and virulence mechanisms of uropathogenic Escherichia coli.

Wiles TJ, Kulesus RR, Mulvey MA.

Exp Mol Pathol. 2008 Aug;85(1):11-9. doi: 10.1016/j.yexmp.2008.03.007. Epub 2008 Apr 8. Review.

38.

Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli.

Kulesus RR, Diaz-Perez K, Slechta ES, Eto DS, Mulvey MA.

Infect Immun. 2008 Jul;76(7):3019-26. doi: 10.1128/IAI.00022-08. Epub 2008 May 5.

39.

Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.

Wiles TJ, Dhakal BK, Eto DS, Mulvey MA.

Mol Biol Cell. 2008 Apr;19(4):1427-38. doi: 10.1091/mbc.E07-07-0638. Epub 2008 Jan 30.

40.

Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.

Eto DS, Jones TA, Sundsbak JL, Mulvey MA.

PLoS Pathog. 2007 Jul;3(7):e100.

41.

Flushing bacteria out of the bladder.

Eto DS, Mulvey MA.

Nat Med. 2007 May;13(5):531-2. No abstract available.

PMID:
17479092
42.

Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli.

Eto DS, Sundsbak JL, Mulvey MA.

Cell Microbiol. 2006 Apr;8(4):704-17.

PMID:
16548895
43.
44.

Contact-dependent inhibition: bacterial brakes and secret handshakes.

Slechta ES, Mulvey MA.

Trends Microbiol. 2006 Feb;14(2):58-60. Epub 2006 Jan 4.

PMID:
16387500
45.

Covert operations of uropathogenic Escherichia coli within the urinary tract.

Bower JM, Eto DS, Mulvey MA.

Traffic. 2005 Jan;6(1):18-31. Review.

46.

CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli.

Schilling JD, Martin SM, Hunstad DA, Patel KP, Mulvey MA, Justice SS, Lorenz RG, Hultgren SJ.

Infect Immun. 2003 Mar;71(3):1470-80.

47.

Adhesion and entry of uropathogenic Escherichia coli.

Mulvey MA.

Cell Microbiol. 2002 May;4(5):257-71. Review.

PMID:
12027955
48.

Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli.

Mysorekar IU, Mulvey MA, Hultgren SJ, Gordon JI.

J Biol Chem. 2002 Mar 1;277(9):7412-9. Epub 2001 Dec 13.

49.
50.

Dynamic interactions between host and pathogen during acute urinary tract infections.

Schilling JD, Mulvey MA, Hultgren SJ.

Urology. 2001 Jun;57(6 Suppl 1):56-61. Review.

PMID:
11378051

Supplemental Content

Loading ...
Support Center